GC/MS n analysis of the crude reaction mixtures from Friedel–Crafts acylation: Unambiguous identification and differentiation of 3‐aroylbenzofurans from their 4‐ and 6‐regioisomers-Reference-Cited by-同舟云学术

GC/MS n analysis of the crude reaction mixtures from Friedel–Crafts acylation: Unambiguous identification and differentiation of 3‐aroylbenzofurans from their 4‐ and 6‐regioisomers

Published:2021-05-05 Issue:11 Volume:35 Page:
ISSN:0951-4198
Container-title:Rapid Communications in Mass Spectrometry
language:en
Short-container-title:Rapid Commun Mass Spectrom

Author:

Begala Michela¹^ORCID,Mancinelli Michele²^ORCID,Quezada Elias³^ORCID,Delogu Giovanna Lucia¹^ORCID

Affiliation:

1. Department of Life and Environmental Sciences University of Cagliari, Cittadella Universitaria s.p.8, 09042 Monserrato Cagliari Italy

2. Department of Industrial Chemistry “Toso Montanari” University of Bologna Viale del Risorgimento 4 Bologna 40136 Italy

3. Department of Organic Chemistry University of Santiago de Compostela Santiago de Compostela 15782 Spain

Funder

Foundation for Ichthyosis and Related Skin Types

Publisher

Wiley

Subject

Organic Chemistry,Spectroscopy,Analytical Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/rcm.9082

Reference24 articles.

1. Amiodarone in Patients with Congestive Heart Failure and Asymptomatic Ventricular Arrhythmia

2. LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation;Felder CC;Pharmacol Exp Ther,1998

3. Benzbromarone

4. BrennerLM BrushCK.US Patent 1997;4 001 426.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regioselective synthesis of new EWG-Bearing 3-benzoyl-2-phenylbenzofurans by one-pot intramolecular acylation/thermal cyclization of phosphoranes and their CB1 antagonist activity;Tetrahedron;2024-03

2. Regioselective Synthesis of New Ewg†-Bearing 3-Benzoyl-2-Phenylbenzofurans by One-Pot Intramolecular Acylation/Thermal Cyclization of Phosphoranes and Their Cb1 Antagonist Activity;2023